Annemijn Vis

Papers

Total Citations

H-Index

About

Annemijn Vis is a pioneering researcher at the forefront of bioengineering and cardiovascular medicine, dedicated to revolutionizing treatment for end-stage heart failure. Her work focuses on developing next-generation total artificial hearts (TAHs) that overcome the biocompatibility and quality-of-life limitations of current mechanical pumps. Vis’s major contribution is her visionary concept of a soft robotic total artificial hybrid heart, which replaces rigid, failure-prone components with flexible, biomimetic materials and soft robotic actuation. This paradigm shift aims to create a TAH that functions as seamlessly as a donor heart, reducing thrombosis, infection, and mechanical wear. Her most-cited paper, “The ongoing quest for the first total artificial heart as destination therapy” (2022, 43 citations), provides a critical roadmap for achieving long-term, implantable cardiac replacement. In her 2025 work (9 citations), she details the hybrid design, where soft robotics provide pumping power and an inner lining mimics native tissue. With over 50 total citations, Vis is shaping the future of cardiac replacement therapy, asking whether a robot can truly match a donor heart. Her innovative approach promises to transform the lives of thousands awaiting transplantation.